Shockwave Medical Inc Net Income per Employee (SWAV), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Shockwave Medical Inc   (NASDAQ: SWAV)
 

Shockwave Medical Inc Net Income per Employee

SWAV's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 41.46% in the first quarter 2024, year on year to cumulative value of $163 million, and with 253 employees, Shockwave Medical Inc 's income per employee grew on trailing twelve month basis to $ 646,241. The income per employee at Shockwave Medical Inc ' was above the company average.
The Healthcare sector has seen employees of 3 other companies achieving higher income per employee. While Shockwave Medical Inc 's total ranking has deteriorated compared to the previous quarter from 190 to 213.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SWAV Net Income per Employee (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Net Income Change 41.46 % -68.56 % -0.05 % 12.91 % 169.44 %
Net Income per Employee (TTM) $ 646,241 582,126 963,968 964,036 950,988
SWAV's Total Ranking # 213 # 190 # 157 # 113 # 160
Seq. Net Income Change 24.92 % 26.64 % 21.22 % -26.23 % -72.23 %

SWAV Company Profile >> Back to SWAV Efficiency Comparisons >> Compare SWAV Net Income per Employee to its Competitors

SWAV Net Income per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 4
Healthcare Sector # 20
Overall Market # 213

Net Income per Employee Statistics
High Average Low
$ 964,036 $ 195,723 $ -278,755
(Jun 30 2023)   (Mar 31 2021)







Companies with similar Income per Employee for 12 month ending Mar 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2024Number of Employees Mar 31 2024
Spero Therapeutics Inc   936,120.00 $ 23.403  Million 25 
Prestige Consumer Healthcare Inc   851,515.79 $ 485.364  Million 570 
Halozyme Therapeutics Inc   753,669.03 $ 318.802  Million 423 
United Therapeutics Corporation  750,357.14 $ 1,050.500  Million 1,400 
Semler Scientific inc   699,580.65 $ 21.687  Million 31 
Orgenesis Inc   669,428.57 $ 51.546  Million 77 
Shockwave Medical Inc   646,241.11 $ 163.499  Million 253 
Tenax Therapeutics Inc   631,422.06 $ 10.103  Million 16 
Glucotrack Inc   582,533.33 $ 8.738  Million 15 
Third Harmonic Bio Inc   558,396.23 $ 29.595  Million 53 
Xeris Biopharma Holdings Inc   532,461.54 $ 34.610  Million 65 
Tevogen Bio Holdings Inc   511,341.17 $ 9.204  Million 18 
Tectonic Therapeutic Inc   505,100.00 $ 30.306  Million 60 
Harmony Biosciences Holdings inc   469,972.70 $ 137.702  Million 293 
Interpace Biosciences Inc   467,598.04 $ 47.695  Million 102 
Scienture Holdings Inc   453,379.11 $ 4.080  Million 9 
Exelixis Inc   404,153.44 $ 463.564  Million 1,147 
Entera Bio Ltd   396,181.82 $ 8.716  Million 22 
Lantheus Holdings Inc   386,030.18 $ 460.534  Million 1,193 
Entrada Therapeutics Inc   379,901.32 $ 57.745  Million 152 
Catalyst Pharmaceuticals Inc   357,785.71 $ 65.117  Million 182 
Dariohealth Corp   325,921.21 $ 53.777  Million 165 


Date modified: 2026-08-29T17:40:56+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.